Ying-Ying Zheng Selected Research

Metabolic Syndrome (Dysmetabolic Syndrome X)

1/2023	Mutated CYP17A1 promotes atherosclerosis and early-onset coronary artery disease.
12/2019	Triglyceride to high-density lipoprotein cholesterol ratio as a predictor of long-term mortality in patients with coronary artery disease after undergoing percutaneous coronary intervention: a retrospective cohort study.
1/2016	Optimal cutoff of the triglyceride to high-density lipoprotein cholesterol  ratio to detect cardiovascular risk factors among Han adults in Xinjiang.
6/2015	Waist-to-Height Ratio and Triglycerides/High-Density Lipoprotein Cholesterol Were the Optimal Predictors of Metabolic Syndrome in Uighur Men and Women in Xinjiang, China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ying-Ying Zheng Research Topics

Disease

31	Coronary Artery Disease (Coronary Atherosclerosis) 10/2023 - 03/2015
9	Coronary Disease (Coronary Heart Disease) 03/2024 - 12/2015
7	Hemorrhage 03/2024 - 06/2019
5	Hypertension (High Blood Pressure) 01/2023 - 01/2011
5	Myocardial Infarction 01/2021 - 01/2013
5	Cardiovascular Diseases (Cardiovascular Disease) 10/2019 - 08/2011
4	Inflammation (Inflammations) 01/2024 - 01/2012
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023 - 06/2015
4	Insulin Resistance 01/2023 - 12/2013
4	Stroke (Strokes) 01/2021 - 11/2010
4	Death (Near-Death Experience) 01/2021 - 01/2018
4	Neoplasms (Cancer) 01/2021 - 03/2020
3	Thrombosis (Thrombus) 01/2021 - 01/2013
3	Dyslipidemias (Dyslipidemia) 08/2020 - 08/2018
2	Atherosclerosis 01/2024 - 01/2023
2	Acute Coronary Syndrome 11/2023 - 03/2021
2	Heart Failure 10/2023 - 01/2019
2	Liver Diseases (Liver Disease) 01/2021 - 06/2019
2	Ischemic Stroke 01/2020 - 01/2015
2	ST Elevation Myocardial Infarction 01/2019 - 06/2018
1	Myocarditis (Carditis) 02/2024
1	Pancreatitis 04/2023
1	Glucose Intolerance 01/2023
1	Abdominal Obesity 01/2023
1	Fatty Liver 01/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Diabetes Mellitus 01/2022
1	Experimental Melanoma 01/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Cardiomyopathies (Cardiomyopathy) 05/2021
1	Dementia (Dementias) 01/2021
1	Multiple Sclerosis 01/2021
1	Eczema 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021
1	End Stage Liver Disease 01/2021
1	Pulmonary Embolism 01/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 06/2019
1	Carcinoma (Carcinomatosis) 06/2019
1	Pathologic Constriction (Stenosis) 01/2018
1	Stable Angina 07/2017
1	Unstable Angina 07/2017
1	Infections 06/2012
1	Chronic Hepatitis C 06/2012

Drug/Important Bio-Agent (IBA)

7	HDL CholesterolIBA 07/2023 - 06/2015
6	AlbuminsIBA 10/2023 - 01/2020
5	omega-Chloroacetophenone (Mace)IBA 03/2024 - 06/2019
5	Triglycerides (Triacylglycerol)IBA 12/2019 - 11/2010
3	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2020
3	Fibrinogen (Factor I)FDA Link 10/2023 - 01/2020
3	TransferasesIBA 01/2020 - 01/2019
3	Serum Amyloid A Protein (Serum Amyloid A)IBA 12/2013 - 08/2011
3	CholesterolIBA 04/2012 - 11/2010
2	Cytochrome P-450 CYP2C19IBA 07/2023 - 01/2013
2	Hemoglobins (Hemoglobin)IBA 07/2023 - 01/2022
2	BilirubinIBA 01/2023 - 10/2017
2	CreatinineIBA 01/2023 - 01/2012
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022 - 01/2021
2	Serum AlbuminIBA 05/2021 - 01/2021
2	Blood Glucose (Blood Sugar)IBA 12/2020 - 08/2018
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 08/2020 - 03/2020
2	Indicators and Reagents (Reagents)IBA 08/2018 - 01/2016
2	HDL LipoproteinsIBA 04/2012 - 01/2011
1	Antiviral Agents (Antivirals)IBA 02/2024
1	Apolipoproteins E (ApoE)IBA 01/2024
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Nonesterified Fatty Acids (NEFA)IBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022
1	pro-brain natriuretic peptide (1-76)IBA 01/2022
1	kojic acidIBA 01/2022
1	C-Reactive ProteinIBA 05/2021
1	Clopidogrel (Plavix)FDA Link 01/2021
1	Alkaline PhosphataseIBA 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021
1	Selenoproteins (Selenoprotein)IBA 08/2020
1	Lipoprotein(a)IBA 08/2020
1	fibrin fragment D (D-dimer)IBA 01/2020
1	Dehydroepiandrosterone (DHEA)IBA 11/2019
1	LipidsIBA 01/2019
1	lipoprotein cholesterolIBA 01/2019
1	Erythropoietin FDA Link 06/2018
1	Phenobarbital (Luminal)FDA Link 01/2018
1	ResistinIBA 07/2017
1	Dehydroepiandrosterone SulfateIBA 05/2017
1	Heme Oxygenase-1IBA 12/2016
1	Apolipoprotein C-IIIIBA 01/2016
1	Apolipoproteins B (ApoB)IBA 12/2015
1	ApolipoproteinsIBA 12/2015
1	Gonadal Steroid Hormones (Sex Hormones)IBA 03/2015
1	Interleukin-10 (Interleukin 10)IBA 01/2015
1	Ribavirin (Virazole)FDA LinkGeneric 06/2012
1	InterferonsIBA 06/2012
1	LDL Lipoproteins (beta Lipoproteins)IBA 04/2012

Therapy/Procedure

29	Percutaneous Coronary Intervention 03/2024 - 01/2013
8	Therapeutics 03/2024 - 11/2011
4	Stents 01/2021 - 01/2013
1	Operative Surgical Procedures 04/2023
1	Resistance Training 04/2023
1	Drug-Eluting Stents 01/2018